輸入代號或公司名稱後按 Enter
ARDX

ARDELYX, INC.

+0.06 (+1.77%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 製藥SIC 2834
3.45USD1.2M成交股數860M市值本益比(近四季)1.9股價營收比+23.8%營收年增(近四季)2026-10-29下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收121M+63%94.5M-19%110M+12%97.7M+33%74.1M+61%116M+106%98.2M+340%73.2M+544%46.0M56.4M22.3M11.4M
營業成本5.8M4.8M4.0M12.4M12.3M18.3M15.7M9.4M7.1M7.7M3.5M1.5M
毛利115M+86%89.7M-8%106M+29%85.3M+34%61.8M+59%97.9M+101%82.5M+338%63.8M+549%38.9M48.7M18.8M9.8M
毛利率95.2%94.9%96.4%87.3%83.4%84.3%84.0%87.1%84.5%86.4%84.4%86.5%
研發費用26.1M20.2M18.1M15.7M14.9M13.7M15.3M12.8M10.6M8.6M8.3M9.1M
銷售管理費用101M102M83.6M84.0M83.2M76.1M65.0M64.7M53.0M32.7M27.2M26.8M
營業利益−12.4M-66%−32.8M-504%4.7M+109%−14.4M+6%−36.3M+47%8.1M+10%2.2M-113%−13.6M-48%−24.7M7.4M−16.6M−26.1M
營業利益率-10.3%-34.7%4.2%-14.7%-49.0%7.0%2.3%-18.6%-53.6%13.1%-74.4%-229.3%
稅後淨利−16.7M-59%−37.6M-887%−969K+20%−19.1M+16%−41.1M+55%4.8M-28%−809K-95%−16.5M-39%−26.5M6.6M−17.1M−26.8M
淨利率-13.8%-39.8%-0.9%-19.5%-55.5%4.1%-0.8%-22.5%-57.6%11.8%-76.7%-235.5%
稀釋 EPS-0.07-59%-0.15-1600%0.00-0.08+14%-0.17+55%0.01-67%0.00-100%-0.07-46%-0.110.03-0.08-0.13
稀釋股數248M246M242M240M239M235M236M235M233M228M215M207M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金97.2M31.2M42.7M90.0M30.8M64.9M47.4M41.9M36.1M33.8M30.1M92.5M
應收帳款100M82.8M76.6M62.6M46.5M57.7M53.2M37.2M28.2M43.3M9.1M12.1M
存貨139M128M129M123M106M91.2M85.2M83.4M78.9M47.5M47.9M44.9M
總資產576M505M486M467M410M436M368M343M342M289M211M217M
有息負債252M204M202M201M151M151M101M100M99.8M27.2M27.1M26.9M
總負債427M356M332M327M265M262M210M196M191M98.2M88.0M91.6M
股東權益149M149M154M140M146M173M158M147M151M191M123M125M
負債比74.1%70.5%68.3%70.1%64.5%60.2%57.0%57.2%55.9%33.9%41.7%42.2%
淨現金(現金 − 有息負債)−155M−172M−159M−111M−120M−85.9M−53.3M−58.4M−63.7M6.5M3.0M65.6M

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流−32.2M−38.5M+8%−35.7M−44.8M
資本支出69K325K150K14K
自由現金流−32.3M−38.8M+8%−35.9M−44.8M
折舊攤銷915K602K435K−3K
買回庫藏股
現金股利
自由現金流率-34.2%-52.3%-77.9%-394.1%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 407M
Reportable407M100.0%+22.1%
地區2025 年度 · 407M
美國378M92.8%+18.4%
亞太29.2M7.2%+103.4%
North America342K0.1%+338.5%
產品/服務2025 年度 · 407M
Product IBSRELA274M67.3%+73.2%
Product XPHOZAH104M25.4%-35.6%
Product Supply Revenue15.9M3.9%+36.3%
Non Cash Royalty Related To Sale Of Future Royalties8.5M2.1%+217.4%
License5.1M1.2%+6423.1%
產品 小計378M92.8%+18.4%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025407M+22.1%−62.0M-15.2%-0.26−44.0M
FY2024334M+168.1%−39.0M-11.7%-0.17−45.8M
FY2023124M+138.6%−66.0M-53.0%-0.30−90.1M
FY202252.2M+416.6%−67.0M-128.5%-0.42−70.1M
FY202110.1M+33.4%−158M-1,564.8%-1.52−154M
FY20207.6M+43.4%−94.3M-1,245.7%-1.05−81.8M
FY20195.3M+102.6%−94.9M-1,797.8%-1.47−76.8M
FY20182.6M−91.3M-3,502.0%-1.62−70.6M